Profarma reports a loss of R$ 1.7 million in the first quarter of 2026
Profarma, a pharmaceutical distributor and owner of the D1000 pharmacy chain, reported a net loss of R$ 1.7 million in the first quarter of 2026. In the same period of the previous year, the company had posted a profit of R$ 11.7 million.
The result shows a change in the company’s performance compared with the first quarter of 2025. The reversal from profit to loss was disclosed by the company in its financial statements.
Profarma operates in pharmaceutical distribution and also in pharmaceutical retail through the D1000 chain. These two businesses are part of the company’s operations in the health and pharmacy sector.
The figures presented refer to the beginning of 2026 and show a more difficult scenario for the company compared with the previous year. So far, the main information disclosed is the change from profit to loss in the quarter.
As a result, the first-quarter financial report indicates that Profarma began 2026 with a negative result. The company’s performance will be monitored by the market in the coming months to assess the evolution of its operations.